Literature DB >> 9831204

The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma.

S R Granter1, A A Renshaw, H P Kozakewich, J A Fletcher.   

Abstract

Chondromyxoid fibroma is a benign bone tumor that arises most commonly in the metaphysis of long bones in young adults. The cytogenetic features of this tumor are not well known. In this study, four chondromyxoid fibromas were karyotyped after short-term cell culture. All of the tumors contained clonal rearrangements of chromosome 6, and each of these rearrangements involved band 6q13. Two tumors contained a pericentromeric inversion, inv (6)(p25q13), which was described recently in chondromyxoid fibroma. 6q13 rearrangements are not associated with other types of bone and soft tissue tumors, and the inv (6)(p25q13) is reported only in chondromyxoid fibroma. Hence, this cytogenetic marker might be helpful in distinguishing chondromyxoid fibroma from chondrosarcoma and other histologic mimics. The consistent occurrence of 6q13 rearrangements suggests a specific oncogenic mechanism in chondromyxoid fibroma, most likely involving oncogene activation.

Entities:  

Mesh:

Year:  1998        PMID: 9831204

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  Molecular pathology of chondroid neoplasms: part 1, benign lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-09-23       Impact factor: 2.199

2.  Aggressive tibial lesion in a 70-year-old man.

Authors:  Jacob M Kirsch; Andrew E Rosenberg; Brian J O'Hara; John A Abraham
Journal:  Clin Orthop Relat Res       Date:  2014-05-28       Impact factor: 4.176

3.  Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes.

Authors:  Salvatore Romeo; Ronald A J Duim; Julia A Bridge; Fredrik Mertens; Danielle de Jong; Paola Dal Cin; Pauline M Wijers-Koster; Maria Debiec-Rychter; Raf Sciot; Andrew E Rosenberg; Karoly Szuhai; Pancras C W Hogendoorn
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

4.  Cytological Diagnosis of Chondromyxoid Fibroma.

Authors:  Purushotham Reddy; S M Choukimath; A A Hosangadi; P V Nishath
Journal:  J Cytol       Date:  2022-06-01       Impact factor: 1.577

5.  Chondromyxoid fibroma of zygoma: A rare case report.

Authors:  M Sudhakara; Radhika M Bavle; N Srinath; K Paremala
Journal:  J Oral Maxillofac Pathol       Date:  2014-01

6.  Aberrations of 6q13 mapped to the COL12A1 locus in chondromyxoid fibroma.

Authors:  Taketoshi Yasuda; Jun Nishio; Janos Sumegi; Kayla M Kapels; Pamela A Althof; Jeffrey R Sawyer; John D Reith; Julia A Bridge
Journal:  Mod Pathol       Date:  2009-07-31       Impact factor: 7.842

7.  Temporal Chondroblastoma with a Novel Chromosomal Translocation (2;5) (q33;q13).

Authors:  Andrew P Carlson; Howard Yonas; Garth T Olson; Kaaren K Reichard; Rafael Medina-Flores
Journal:  Skull Base Rep       Date:  2011-03-25

8.  Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites.

Authors:  Henry B Armah; Richard L McGough; Mark A Goodman; Susanne M Gollin; Urvashi Surti; Anil V Parwani; Uma N M Rao
Journal:  Diagn Pathol       Date:  2007-11-24       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.